A Study to Compare the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Volunteers With Severe Renal Impairment Who Are Not Being Treated With Hemodialysis Versus Healthy Adult Volunteers.

Trial Profile

A Study to Compare the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Volunteers With Severe Renal Impairment Who Are Not Being Treated With Hemodialysis Versus Healthy Adult Volunteers.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2012

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Dyslipidaemias; Hypercholesterolaemia; Hyperlipidaemia
  • Focus Pharmacokinetics
  • Sponsors Kowa Research Institute
  • Most Recent Events

    • 10 Aug 2012 Primary end point added as reported by ClinicalTrials.gov record.
    • 21 Mar 2012 Actual end date (1 Dec 2010) added as reported by ClinicalTrials.gov.
    • 21 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top